Related Experiment Videos
Hereditary macrothrombocytopenia and pregnancy
A Altès1, N Pujol-Moix, E Muñiz-Díaz
1Department of Haematology, Hospital de la Santa Creu I Sant Pau de Barcelona, Spain.
Thrombosis and Haemostasis
|July 1, 1996
Summary
Hereditary macrothrombocytopenias (HM) are rare but more common in pregnant women than previously thought. Vaginal delivery is safe for these patients, with no prophylactic treatment needed unless specific risks are present.
Area of Science:
- Hematology
- Obstetrics
- Genetics
Background:
- Hereditary macrothrombocytopenias (HM) are uncommon genetic disorders.
- Characterized by abnormally large platelets.
- Limited data exists on HM during pregnancy and childbirth.
Observation:
- A study of 40 thrombocytopenic pregnant women identified four cases of HM.
- All diagnosed cases presented with giant platelets and characteristic ultrastructural findings.
- One case showed Döhle-like inclusions in granulocytes; only one case had detectable platelet antibodies.
Findings:
- The prevalence of HM among thrombocytopenic pregnant women was higher than anticipated.
- No prophylactic measures were used, yet all patients had uncomplicated vaginal deliveries.
- Neither mothers nor infants experienced hemorrhagic events.
Implications:
- HM diagnosis in pregnant women may be underestimated.
- Routine prophylactic treatment for HM in pregnancy can likely be avoided without a history of bleeding or specific obstetrical risks.
- This suggests a potentially safer approach to managing HM during childbirth.